Theravance Biopharma (TBPH)
17.08
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form DEFA14A Theravance Biopharma,
August 25, 2026 4:54 PM - SEC Filing
Form 8-K Theravance Biopharma, For: Aug 25
August 25, 2026 4:53 PM - SEC Filing
Form 4 Theravance Biopharma, For: Aug 20 Filed by: Winningham Rick E
August 24, 2026 6:09 PM - SEC Filing
Form 4 Theravance Biopharma, For: Aug 20 Filed by: Sawaf Aziz
August 24, 2026 6:08 PM - SEC Filing
Form 4 Theravance Biopharma, For: Aug 20 Filed by: Miller Aine
August 24, 2026 6:05 PM - SEC Filing
Form 4 Theravance Biopharma, For: Aug 20 Filed by: Grimaud Brett A.
August 24, 2026 6:03 PM - SEC Filing
Form 4 Theravance Biopharma, For: Aug 20 Filed by: Farnum Rhonda
August 24, 2026 6:00 PM - SEC Filing
Form DEFM14A Theravance Biopharma,
August 21, 2026 6:28 AM - SEC Filing
Form SCHEDULE 13G/A Theravance Biopharma, Filed by: Newtyn Management, LLC
August 14, 2026 4:23 PM - SEC Filing
Form SCHEDULE 13G/A Theravance Biopharma, Filed by: Madison Avenue Partners, LP
August 14, 2026 10:09 AM - SEC Filing
Form PREM14A Theravance Biopharma, For: Aug 11
August 11, 2026 8:14 AM - SEC Filing
Form 10-Q Theravance Biopharma, For: Jun 30
August 11, 2026 8:01 AM - SEC Filing
Form 8-K Theravance Biopharma, For: Aug 10
August 10, 2026 8:35 AM - SEC Filing
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026 8:30 AM - PR NewsWire
Form 4 Theravance Biopharma, For: Jul 06 Filed by: Samaha Eli
July 8, 2026 4:14 PM - SEC Filing
H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral
July 7, 2026 7:37 AM - StreetInsider
Form 4 Theravance Biopharma, For: Jun 29 Filed by: Samaha Eli
July 1, 2026 7:34 PM - SEC Filing
BTIG Downgrades Theravance Biopharma (TBPH) to Neutral
June 29, 2026 9:20 AM - StreetInsider
Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
June 29, 2026 8:34 AM - StreetInsider
Form DEFA14A Theravance Biopharma,
June 29, 2026 6:32 AM - SEC Filing
Form 8-K Theravance Biopharma, For: Jun 28
June 29, 2026 6:31 AM - SEC Filing
Zymeworks to acquire Theravance Biopharma for $17 per share
June 29, 2026 6:01 AM - StreetInsider
Zymeworks to buy Theravance Biopharma for $17 per share
June 29, 2026 6:00 AM - StreetInsider
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
June 29, 2026 6:00 AM - PR NewsWire
Zymeworks to Acquire Theravance Biopharma, Inc.
June 29, 2026 6:00 AM - StreetInsider
Form 4 Theravance Biopharma, For: Jun 19 Filed by: Miller Aine
June 23, 2026 5:49 PM - SEC Filing
Form 8-K Theravance Biopharma, For: Jun 19
June 23, 2026 5:03 PM - SEC Filing
Form 4 Theravance Biopharma, For: Jun 15 Filed by: Farnum Rhonda
June 17, 2026 7:56 PM - SEC Filing
Form 4 Theravance Biopharma, For: Jun 12 Filed by: Smaldone Alsup Laurie
June 16, 2026 9:41 PM - SEC Filing
Form 4 Theravance Biopharma, For: Jun 12 Filed by: GRAY SUSANNAH
June 16, 2026 9:40 PM - SEC Filing
Form 4 Theravance Biopharma, For: Jun 12 Filed by: MITCHELL DEAN J
June 16, 2026 9:38 PM - SEC Filing
Form 4 Theravance Biopharma, For: Jun 12 Filed by: O'Connor Donal
June 16, 2026 9:37 PM - SEC Filing
Form 4 Theravance Biopharma, For: Jun 12 Filed by: PAKIANATHAN DEEPIKA
June 16, 2026 9:36 PM - SEC Filing
Form 144 Theravance Biopharma, Filed by: Farnum Rhonda
June 15, 2026 5:26 PM - SEC Filing
Form 8-K Theravance Biopharma, For: Jun 12
June 12, 2026 5:00 PM - SEC Filing
Full Article List
